Iken Tissue Therapeutics Names CFO, Clinical Development Posts

SAN FRANCISCO--(BUSINESS WIRE)--Feb. 16, 2005--Iken Tissue Therapeutics President and Chief Executive Officer Michael Siani-Rose today announced the appointments of Deirdre Henry as Chief Financial Officer and Michael Flashner, Ph.D. as Vice President, Medical and Regulatory Affairs for the Company.

MORE ON THIS TOPIC